title: Use of composite endpoints in clinical trials.
authors.affiliation: Synageva BioPharma, 33 Hayden Avenue, Lexington, MA, 02421, USA.
authors.forename: Abdul J
authors.initials: AJ
authors.lastname: Sankoh
authors.affiliation: Merrimack Pharmaceuticals, One Kendall Square, Cambridge, MA, 02139, USA.
authors.forename: Haihong
authors.initials: H
authors.lastname: Li
authors.affiliation: Boston University, 111 Cummington Street, Boston, MA, 02215, USA.
authors.forename: Ralph B
authors.initials: RB
authors.lastname: D'Agostino
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D004341:Drug Evaluation / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans